InChI=1S/C20H34O5/c1- 2- 3- 6- 9- 15(21) 12- 13- 17- 16(18(22) 14- 19(17) 23) 10- 7- 4- 5- 8- 11- 20(24) 25/h12- 13,15- 17,19,21,23H,2- 11,14H2,1H3,(H,24,25) /b13- 12+/t15- ,16+,17+,19+/m0/s1 |
GMVPRGQOIOIIMI-DWKJAMRDSA-N |
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O |
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
|
|
vasodilator agent
A drug used to cause dilation of the blood vessels.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
anticoagulant
An agent that prevents blood clotting.
|
|
View more via ChEBI Ontology
(13E,15S)-11α,15-dihydroxy-9-oxoprost-13-en-1-oic acid
|
alprostadil
|
WHO MedNet
|
alprostadil
|
KEGG DRUG
|
alprostadilum
|
ChemIDplus
|
(11α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
|
ChemIDplus
|
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
|
KEGG COMPOUND
|
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
|
KEGG COMPOUND
|
11α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid
|
ChemIDplus
|
Alprostadil
|
KEGG COMPOUND
|
PGE-1
|
ChemIDplus
|
PGE1
|
ChEBI
|
PGE1
|
KEGG COMPOUND
|
Prostaglandin E1
|
KEGG COMPOUND
|
Befar
|
KEGG DRUG
|
Caverject
|
DrugBank
|
Edex
|
DrugBank
|
Muse
|
DrugBank
|
Prostin VR
|
DrugBank
|
2061617
|
Reaxys Registry Number
|
Reaxys
|
745-65-3
|
CAS Registry Number
|
KEGG COMPOUND
|
745-65-3
|
CAS Registry Number
|
ChemIDplus
|
15295081
|
PubMed citation
|
Europe PMC
|
18176061
|
PubMed citation
|
Europe PMC
|
7732902
|
PubMed citation
|
Europe PMC
|
|